1st Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Martin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Front Immunol. 2018 Mar 27;9:609. doi: 10.3389/fimmu.2018.00609. eCollection 2018.
Testing for liver-related autoantibodies should be included in the workup of patients with hepatitis or cholestasis of unknown origin. Although most of these autoantibodies are not disease specific, their determination is a prerequisite to diagnose autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC), and they are components of the diagnostic scoring system in these diseases. In primary sclerosing cholangitis (PSC), on the other hand, autoantibodies are frequently present but play a minor role in establishing the diagnosis. In PSC, however, data on antibodies suggest a link between disease pathogenesis and the intestinal microbiota. This review will focus on practical aspects of antibody testing in the three major autoimmune liver diseases AIH, PBC, and PSC.
检测与肝脏相关的自身抗体应该包括在不明原因的肝炎或胆汁淤积症患者的检查中。尽管这些自身抗体大多数没有疾病特异性,但它们的测定是诊断自身免疫性肝炎(AIH)和原发性胆汁性胆管炎(PBC)的前提,也是这些疾病诊断评分系统的组成部分。另一方面,在原发性硬化性胆管炎(PSC)中,自身抗体通常存在,但在确定诊断方面作用较小。然而,在 PSC 中,有关抗体的数据表明疾病发病机制与肠道微生物群之间存在联系。这篇综述将重点介绍 AIH、PBC 和 PSC 这三种主要的自身免疫性肝病中抗体检测的实际方面。